Cas No.: | 1820812-16-5 |
Chemical Name: | 4-fluoro-2-[(3S,4S)-4-hydroxytetrahydro-2H-pyran-3-yl]-5-methyl-6-[4-(1H-pyrazol-1-yl)benzyl]-2,3-dihydro-1H-isoindol-1-one |
Synonyms: | TAK071;TAK 071 |
SMILES: | C(=O)1C2=C(C(F)=C(C)C(CC3=CC=C(N4C=CC=N4)C=C3)=C2)CN1[C@H]1[C@H](O)CCOC1 |
Formula: | C24H24FN3O3 |
M.Wt: | 421.472 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | TAK-071 is a novel muscarinic acetylcholine receptor 1 (M1R) positive allosteric modulator. EC50 of TAK-071 M1R agonist activities is 520 nM[1]. |
Target: | EC50: 520 nM (M1R)[1] |
References: | [1]. Sako Y, et al. TAK-071, a novel M1 positive allosteric modulator with low cooperativity, improves cognitive function in rodents with few cholinergic side effects. Neuropsychopharmacology. 2018 Aug 1. doi: 10.1038/s41386-018-0168-8. |